NX vs TECH · rev $1.28B vs P/E 65, rev $1.22B
Quanex Building Products (NX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Quanex Building Products (NX) is a building products & equipment company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NX revenue for 2024-10-31 was $1.28B. Net income was $33.1M. Revenue was up 13.0% from 2023-10-31 to 2024-10-31. NX currently screens at market cap $743.1M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NX currently screens at market cap $743.1M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NX and TECH stock pages for the full models.
Not investment advice.